4.6 Review

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

Journal

TRENDS IN MOLECULAR MEDICINE
Volume 14, Issue 2, Pages 45-53

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2007.12.002

Keywords

-

Funding

  1. NIA NIH HHS [R01 AG028072-02, R01 AG028072, AG026051, AG028072] Funding Source: Medline

Ask authors/readers for more resources

Recent studies of postmortem brains from Alzheimer's disease (AD) patients and transgenic mouse models of AD suggest that oxidative damage, induced by amyloid beta (A beta), is associated with mitochondria early in AD progression. A beta and amyloid-precursor protein are known to localize to mitochondrial membranes, block the transport of nuclear-encoded mitochondrial proteins to mitochondria, interact with mitochondrial proteins, disrupt the electron-transport chain, increase reactive oxygen species production, cause mitochondrial damage and prevent neurons from functioning normally. Furthermore, accumulation of A beta at synaptic terminals might contribute to synaptic damage and cognitive decline in patients with AD. Here, we describe recent studies regarding the roles of A beta and mitochondrial function in AD progression and particularly in synaptic damage and cognitive decline.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available